Antibody Therapeutics for Life

Press Release

No Title Written by Written date Inquire
11   PharmAbcine announces the execution of a Material Cooperative Research and Development Agreement (MCRADA) with the NIH to evaluate the efficacy of PMC-403 to treat SCLS PharmAbcineLogo (PRNewsfoto/PharmAbcine)   PharmAbcine   2020-08-20   3,284  
10   PharmAbcine signs a research collaboration agreement with Wuxi Shuangliang Biotechnology (SLBio) to evaluate a combination therapy to treat NSCLC   PharmAbcine   2020-08-20   376  
9   PharmAbcine to Present Preclinical Data of Blood Vessel Stabilizing PMC-402 at 2020 AACR Meeting   PharmAbcine   2020-05-20   19,376  
8   Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment   PharmAbcine   2020-04-07   16,478  
7   PharmAbcine, Announces Acceptance of Phase Ib Olinvacimab and Pembrolizuamb Combination Trial in rGBM Patients Abstract at the 2020 ASCO Annual Meeting   PharmAbcine   2020-04-06   21,298  
6   PharmAbcine, Olinvacimb, able to manage the first recruitment of patients for phase II clinical trial   PharmAbcine   2019-11-20   17,930  
5   PharmAbcine,BioPharma Dealmakers_sep 2019   PharmAbcine   2019-10-01   15,715  
4   PharmAbcine, Drug Discovery Special APAC 2019   PharmAbcine   2019-09-17   19,931  
3   PharmAbcine, HREC Approval announcement Austin Health   PharmAbcine   2019-08-23   19,947  
2   PharmAbcine Appoints Legendary Pathologist Dr. David Cheresh to Scientific Advisory Board   Admin   2019-03-07   34,329